Physician profile
Ryan Neinstein
NPI 1588929327
$61,755.00
in general payments reported to CMS, 2019-2025
18 companies · $460 in 2025
The $460 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $23K · 2021: $1,213 · 2022: $8,456 · 2023: $27K · 2024: $1,040 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $2,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,600.00 |
| Food and Beverage | $2,822.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $46,787.15 | 2019-2025 | |
| Apyx Medical Corporation | $8,350.38 | 2019-2020 | |
| Merz North America, INC. | $2,843.71 | 2020-2023 | Xeomin |
| Abbvie INC. | $1,095.54 | 2023-2025 | |
| Galderma Laboratories, L.P. | $782.69 | 2019-2024 | Dysport |
| Allergan, INC. | $674.80 | 2020-2022 | |
| Davol INC. | $400.02 | 2022-2025 | Phasix Mesh |
| Motiva USA, LLC | $379.77 | 2024-2025 | |
| Mentor Worldwide LLC | $76.31 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Pacira Pharmaceuticals Incorporated | $73.31 | 2019-2024 | Exparel |
| Sientra, INC. | $60.37 | 2020-2022 | |
| Revance Therapeutics, INC. | $52.89 | 2025 | Daxxify |
| Kowa Pharmaceuticals America, INC. | $51.95 | 2022 | |
| Bard Peripheral Vascular, INC. | $45.67 | 2021 | |
| Kci USA, INC. | $25.43 | 2023 | Prevena |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $24.16 | 2025 | Insorb |
| Smith+Nephew, INC. | $18.39 | 2023 | Collagenase Santyl |
| Tepha INC | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Neinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.